SLC5A3 and cervical cancer: Analysis of TCGA cervical cancer datasets revealed that patients with cervical cancer exhibiting SLC5A3 upregulation were associated with poor overall survival (P = 0.065) (Figure 1B) and progression-free interval (PFI) (P = 0.001, Figure 1C).